Doxorubicin-resistant LoVo adenocarcinoma cells display resistance to apoptosis induction by some but not all inhibitors of ser/thr phosphatases 1 and 2A

This publication has 17 references indexed in Scilit:

• Characterization of two pituitary GH3 Cell sublines partially resistant to apoptosis induction by okadaic acid
  Biochemical Pharmacology, 1997
• The Involvement of Protein Phosphatases in the Activation of ICE/CED-3 Protease, Intracellular Acidification, DNA Digestion, and Apoptosis
  Journal of Biological Chemistry, 1996
• Reversal of multiple drug resistance in vitro by phosphorothioate oligonucleotides and ribozymes
  Anti-Cancer Drugs, 1995
• Characterization of natural toxins with inhibitory activity against serine/threonine protein phosphatases
  Toxicon, 1994
• Cantharidin, another natural toxin that inhibits the activity of serine/threonine protein phosphatases types 1 and 2A
  FEBS Letters, 1993
• BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTER
  Annual Review of Biochemistry, 1993
• The protein phosphatase inhibitor okadaic acid induces morphological changes typical of apoptosis in mammalian cells
  Experimental Cell Research, 1991
• Modulation of multidrug resistance by verapamil or mdr1 anti‐sense oligodeoxynucleotide does not change the high susceptibility to lymphokine‐activated killers in mdr‐resistant human carcinoma (LoVo) line
  International Journal of Cancer, 1990
• THE STRUCTURE AND REGULATION OF PROTEIN PHOSPHATASES
  Annual Review of Biochemistry, 1989
• Isolation and characterization of a human colon adenocarcinoma cell line resistant to doxorubicin
  British Journal of Cancer, 1986